CryoLife (CRY) Tops Q2 EPS by 17c

July 29, 2021 4:52 PM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

CryoLife (NYSE: CRY) reported Q2 EPS of $0.12, $0.17 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $76.1 million versus the consensus estimate of $70.97 million.


CryoLife sees Q3 2021 revenue of $296-300 million, versus the consensus of $294 million.

For earnings history and earnings-related data on CryoLife (CRY) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities